IRIS
CAROTTI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.417
EU - Europa 5.759
AS - Asia 5.577
SA - Sud America 1.453
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 194
OC - Oceania 8
Totale 31.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.028
SG - Singapore 2.153
CN - Cina 1.550
DE - Germania 1.390
IT - Italia 1.336
BR - Brasile 1.170
SE - Svezia 709
HK - Hong Kong 641
RU - Federazione Russa 566
UA - Ucraina 431
VN - Vietnam 400
GB - Regno Unito 387
FI - Finlandia 330
FR - Francia 322
IN - India 183
CA - Canada 181
AR - Argentina 103
BD - Bangladesh 89
IQ - Iraq 67
TR - Turchia 61
IE - Irlanda 57
ID - Indonesia 56
JP - Giappone 56
MX - Messico 55
EC - Ecuador 49
ZA - Sudafrica 49
PK - Pakistan 43
VE - Venezuela 39
BE - Belgio 38
CO - Colombia 38
NL - Olanda 38
IR - Iran 33
PL - Polonia 33
TW - Taiwan 31
CI - Costa d'Avorio 29
PH - Filippine 28
MA - Marocco 27
SA - Arabia Saudita 27
ES - Italia 25
CR - Costa Rica 23
UZ - Uzbekistan 22
GT - Guatemala 20
PY - Paraguay 19
NI - Nicaragua 18
IL - Israele 17
LT - Lituania 17
EG - Egitto 16
MY - Malesia 16
TN - Tunisia 14
TT - Trinidad e Tobago 14
JM - Giamaica 13
SC - Seychelles 13
SV - El Salvador 13
CZ - Repubblica Ceca 12
HN - Honduras 11
NP - Nepal 11
PR - Porto Rico 11
AT - Austria 10
AZ - Azerbaigian 10
BO - Bolivia 10
CL - Cile 10
CW - ???statistics.table.value.countryCode.CW??? 10
GP - Guadalupe 10
KE - Kenya 10
KR - Corea 9
PE - Perù 9
CH - Svizzera 8
DK - Danimarca 8
DZ - Algeria 8
JO - Giordania 8
NG - Nigeria 8
OM - Oman 8
AE - Emirati Arabi Uniti 7
EE - Estonia 7
HU - Ungheria 7
KZ - Kazakistan 7
PS - Palestinian Territory 7
RO - Romania 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
KG - Kirghizistan 5
PA - Panama 5
EU - Europa 4
GE - Georgia 4
LB - Libano 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
AU - Australia 3
BS - Bahamas 3
HR - Croazia 3
KW - Kuwait 3
UY - Uruguay 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CG - Congo 2
CU - Cuba 2
Totale 31.388
Salva come PNG Salva come JPEG
Città #
Dallas 2.107
Fairfield 1.755
Ashburn 1.661
Woodbridge 1.151
Singapore 1.089
Chandler 1.050
Jacksonville 957
San Jose 948
Houston 789
Seattle 682
Hong Kong 636
Wilmington 608
Cambridge 585
Milan 580
Nyköping 486
Ann Arbor 453
Beijing 368
Council Bluffs 300
Nanjing 275
Roxbury 245
Lawrence 241
Lauterbourg 211
New York 176
Boardman 174
Rome 172
Des Moines 160
Princeton 150
Washington 143
Los Angeles 129
Ho Chi Minh City 127
São Paulo 120
Bari 117
Brooklyn 110
Dearborn 99
Santa Clara 98
Helsinki 86
Shenyang 79
Hanoi 77
San Diego 74
Hebei 73
Nanchang 73
Inglewood 66
Jiaxing 61
Dong Ket 59
Munich 59
Buffalo 58
Dublin 57
Figino 52
Chicago 49
Columbus 48
Atlanta 44
Rio de Janeiro 44
North Bergen 43
Tianjin 42
Toronto 42
Moscow 38
Guangzhou 35
Marseille 35
Brussels 34
San Francisco 34
Tokyo 33
Turin 33
Montreal 32
London 30
Abidjan 29
Jinan 29
Redwood City 29
Changsha 28
Kansas City 28
Phoenix 28
Baghdad 27
Johannesburg 27
Shanghai 26
Belo Horizonte 25
Warsaw 25
Zhengzhou 25
Frankfurt am Main 24
Orem 24
Jakarta 23
Brasília 22
Denver 21
Falkenstein 21
Naples 21
Tashkent 21
Augusta 19
Ningbo 19
San Mateo 19
Guatemala City 18
Salvador 18
Caracas 17
Chennai 17
Managua 17
Mexico City 17
Paris 17
Campinas 16
Curitiba 16
Lahore 16
Leawood 16
Nuremberg 16
San José 16
Totale 21.219
Salva come PNG Salva come JPEG
Nome #
1,3-Dialkyl-8-(hetero)aryl-9-OH-9-deazaxanthines as potent A2B adenosine receptor antagonists: design, synthesis, structure-affinity and structure-selectivity relationships 1.106
1,3-Dialkyl-8-N-substituted benzyloxycarbonylamino-9-deazaxanthines as potent adenosine receptor ligands: Design, synthesis, structure-affinity and structure-selectivity relationships 1.089
Applicability Domain for QSAR models: where theory meets reality 274
Design, synthesis and biological evaluation of indane 2-arylhydrazinylmethylene-1,3-diones and indol-2-aryldiazenylmethylene-3-ones as b-amyloid aggregation inhibitors 249
Exploring Basic Tail Modifications of Coumarin-based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-soluble, Brain-permeant Neuroprotective Multitarget Agents 227
Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data 222
BCR-ABL inhibitors in chronic myeloid leukemia: process chemistry and biochemical profile 217
Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases 212
Design, synthesis, and biological evaluation of glycine-based molecular tongs as inhibitors of Aβ40 aggregation in vitro 202
Mind the Gap ! A Journey towards Computational Toxicology 201
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: Proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity 190
Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways 188
Quinolino[3,4-b]quinoxalines and pyridazino[4,3-c]quinoline derivatives: Synthesis, inhibition of topoisomerase IIa, G-quadruplex binding and cytotoxic properties 188
Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds 186
(EN) GALLOYL BENZAMIDE-BASED COMPOUNDS AS JNK MODULATORS (FR) COMPOSES A BASE DE GALLOYL BENZAMIDE UTILISES EN TANT QUE MODULATEURS DE JNK 184
6-Substituted-(E)-2-(benzofuran-3(2H)-ylidene)-N-methylacetamides as novel, potent and selective MAO inhibitors 183
A k-NN algorithm for predicting oral sub-chronic toxicity in the rat 183
A simple Synthesis of Heterocyclic Ring Systems Containing the 1,3-oxazine Nucleus 181
Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 180
Reduction of Aldol Adducts from 1,2,3-Indantrione and Cyclic CH-acid Compounds; Keto-enol Tautomeric Study of Reduction Products 178
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4′-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase 177
Synthesis and antibacterial activity of 2-aryl-2,5-dihydro-3(3H)-oxo-pyridazino4,3-bindole-4-carboxylic acids 177
Linear Solvation Energy Relationships in Reversed-Phase Liquid Chromatography. Examination of Deltabond C8 as Stationary Phase for Measuring Lipophilicity Parameters 176
X-Ray Crystal Structure, Partitioning Behavior and Molecular Modeling Study of Piracetam-type Nootropics: Insights into the Pharmacophore 174
A convenient synthesis of nitriles from primary amides under mild conditions 173
An efficient Route to Biologically Active 5H-Indeno[1,2-c]Pyridazines 173
A simple and Mild Procedure for the Preparation of Bile Acid Methyl Esters 172
A Round Trip from Medicinal Chemistry to Predictive Toxicology 171
8-Aminomethyl-7-hydroxy-4-methylcoumarins as Multitarget Leads for Alzheimer's Disease 171
2-(2-Phenylcyclopropyl)-Imidazolines: Reversed Enantioselective Interaction At I1 and I2 Imidazoline Receptors 170
Searching for Multitargeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE−MAO B Inhibitors through the Decoration of 2H-Chromen-2-one Structural Motif 170
LFER and CoMFA studies on optical resolution of a-alkyl-a-aryloxyacetic acid methyl esters on DACH-DNB chiral stationary phase 168
8-Substituted- 9-deazaxanthines as adenosine receptor ligands: design, synthesis and structure-affinity relationships at A2B 167
Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding 166
Partitioning behaviour of piracetam-type cognition enhancers 165
Integration of QSAR models for bioconcentration suitable for REACH 164
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor 164
Synthesis and antibacterial activity of pyridazino[4,3-b]indole-4-carboxylic acids carrying different substituents at N-2 163
D184E mutation in aquaporin-4 gene impairs water permeability and links to deafness. 163
Computer Aided Structure Based Design of Multitarget Leads for Alzheimer’s Disease 160
Heterocyclic Steroids II. Synthesis of Some Spiro-Derivatives of 7,8-Diaza-11-Oxasteroids 158
Le applicazioni della chimica farmaceutica 157
Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase 156
Indenocinnoline derivatives as G-quadruplex binders, topoisomerase IIα inhibitors and antiproliferative agents 156
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 156
Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mitochondrial respiration 155
Synthesis.and biological evaluation of pyridazino[4,3-b]indoles and indeno[1,2-c]pyridazines as new ligands of central and peripheral benzodiazepine receptors 155
Benzodiazepine receptor affinities, behavioural and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones in mice 154
Discovery, biological evaluation, and structure-activity and -selectivity relationships of 6′-substituted (E)-2-(benzofuran-3(2H)-ylidene)-N- methylacetamides, a novel class of potent and selective monoamine oxidase inhibitors 154
An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors 151
Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9 151
Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases 151
Investigation on platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids 150
Advanced methodologies in medicinal chemistry research 150
Acidi barbiturici contenenti il nucleo dell'indantrione 150
On the Catalytic Reduction of Some 12-spiro-derivatives of 8-aza-11-oxasteroids 150
The practice of medicinal chemistry 149
Determination of Lipophilicity and Hydrogen-bond Donor Acidity of Bioactive Sulphonyl-containing Compounds by Reversed-phase HPLC and Centrifugal Partition Chromatography and their Application to Structure-activity Relations 148
Coumarins Derivatives as Dual Inhibitors of Acetylcholinesterase and Monoamine Oxidase 148
Carbamate Prodrug Concept for Hydroxamate HDAC Inhibitors 147
In Silico Design of Novel 2H-Chromen-2-one Derivatives as Potent and Selective MAO-B Inhibitors 147
SYNTHESIS OF NEW HETEROCYCLIC RING SYSTEMS: INDENO[2,1-B]-BENZO[G]INDOLIZINE AND INDENO[1',2':5,4]PYRROLO[2,1-A]PHTHALAZINE 146
QSAR Analysis of the Subtilisin Hydrolysis of X-Phenyl-Hippurates II. A Study of Subtilisin BPN' 145
Lipophilicity Measurements of Benzenesulfonamide Inhibitors of Carbonic Anhydrase by Reversed-phase HPLC 145
9,10-Anthraquinone hinders beta-aggregation: how does a small molecule interfere with Abeta-peptide amyloid fibrillation? 144
Ligands of neuronal nicotinic acetylcholine receptor (nAChR): inferences from the Hansch and 3-D Quantitative Structure-Activity Relationship (QSAR) models 143
Insights into the complex formed by Matrix Metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations 143
Coumarin, chromone, and 4(3H)-pyrimidinone novel bicyclic and tricyclic derivatives as antiplatelet agents: synthesis, biological evaluation, and comparative molecular field analysis 142
17β-Hydroxysteroid Dehydrogenase Type 2 Inhibition: Discovery of Selective and Metabolically Stable Compounds Inhibiting both the Human Enzyme and its Murine Ortholog 142
QSAR of Teicoplanin Antibiotics: Influence of Lipophilicity and Ionic Properties on their in vivo Antimicrobial Activity 141
Building up QSAR model for toxicity of Psychotropic Drugs by the Monte Carlo method 140
Sintesi di sistemi eterociclici a potenziale attivita farmacologica contenenti un nucleo 1,3-ossazinico 140
Enantiomeric Resolution of Sulfoxides on a DACH-DNB Chiral Stationary Phase: a Quantitative Structure-Enantioselective Retention Relationship (QSERR) Study 140
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 140
Inhibition of MAO by functionalized coumarin derivatives: Biological activities, QSARs and 3D QSARs 139
Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships 139
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on Mitsunobu reaction 139
An easy, high-yield conversion of aldoximes to nitriles 139
A chemocentric approach to the identification of cancer targets 138
Pyrrolo(3,2-c)pyridine derivatives as inhibitors of platelet aggregation 137
Estimation of the Binding Free Energy by Linear Interaction Energy Models 137
An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes 137
Multitarget-directed tricyclic pyridazinones as g protein-coupled receptor ligands and cholinesterase inhibitors. 137
Benzenesulfonamide inhibitors of carbonic anhydrase: study of their hydrophobicity by RPLC. 136
Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives 136
Neuronal nicotinic acetylcholine receptor agonists: Pharmacophores, evolutionary QSAR and 3D-QSAR models 135
Synthesis of 12-mono- and di-substituted 8-aza-11-oxasteroids 133
Studio dell’Idrolisi Chimica e Plasmatica di Aril-nipecotati ad Attività Gaba-mimetica Attraverso Analisi Regressionale 133
3,4-Dihydroquinazoline derivatives as T-type Ca2+ channel blockers inhibit the activities of cholinesterase enzymes 133
2-D and 3-D modeling of imadazoline receptor ligands: insights into pharmacophore 133
Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods 132
Synthesis and anticonvulsant activity of some 1,2,3,3a-tetrahydropyrrolo[2,1-b]-benzothiazol-, -thiazol- or -oxazol-1-ones in rodents. 132
Fine Molecular Tuning at Position 4 of 2H-Chromen-2-one Derivatives in the Search of Potent and Selective Monoamine Oxidase B Inhibitors 132
Design, Synthesis, and 3D QSAR of Novel Potent and Selective Aromatase Inhibitors 131
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models. 131
Solid phase synthesis of a molecular library of pyrimidines, pyrazoles and isoxazoles with biological potential 130
Synthesis and structure-affinity relationships at the central benzodiazepine receptor of pyridazino4,3-bindoles and indeno1,2-cpyridazines 130
Actinidin hydrolysis of substituted-phenyl hippurates: a quantitative structure-activity relationship and graphics comparison with hydrolysis by papain 130
REACH and in silico methods: an attractive opportunity for medicinal chemists 130
Synthesis and Biological Evaluation of Novel Hybrid Molecules Containing Purine, Coumarin and Isoxazoline or Isoxazole Moieties 130
Totale 17.757
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.243 0 0 0 0 77 80 94 84 96 166 296 350
2022/20232.861 472 196 147 284 428 362 16 317 520 15 49 55
2023/2024910 80 172 32 142 60 151 30 31 26 27 25 134
2024/20253.397 99 73 351 131 60 236 180 280 186 163 491 1.147
2025/20269.238 1.026 683 2.016 846 679 393 863 261 609 633 235 994
2026/20272.519 190 374 566 1.316 73 0 0 0 0 0 0 0
Totale 31.693